24Jul 2017

PREVALENCE OF TOXOPLASMOSIS AMONG CANCER PATIENTS.

  • Assistant Lecturer, Institute Of Medical Technology/ Al-Mansur, Baghdad-Iraq.
Crossref Cited-by Linking logo
  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

The objective of the present study is to detect of toxoplasmosis infected patients compared with cancer patients attending the Unit of Tumors in the Medical City, in compared with together healthy individuals as a control group. Enzyme Linked Immunosorbent Assay ELIZA was used to investigate the anti- Toxoplasma gondii antibodies, type IgM and IgG. However, the tumor antibody in serum and its relationship with other affecting factors was detected by Ca19-9 test. The study involved 148 are cancer patients, while 59 are apparently healthy individuals (control group) and 59 are infected with Toxoplasma gondii. Blood specimens were taken from all studied individuals from the period 1st January 2016 to 30th December 2016. Results of this study revealed that 52.24% of cancer patients and 30.5% of the control group had chronic toxoplasmosis disease. 15.73% of cancer patients had acute Toxoplasma infection. However, 33.89% of toxoplasmosis patients had a cute infection. There have been no cases of the control group showed results of the study; also there were no significant differences at the level of probability of P <0.001.


  1. AL-Bajalan, R.R.; AL-Nasiri, F.S. and Mahmood, S. M.. Detection Toxoplasma? gondii by Latex and ELISA test in? infertile and fertile men in Kalar city , Kurdistan? region , Iraq. Int .J.Curr. Microbiol .App.Sci (2015)., 4(10):570-585.
  2. A L-Dabagh, I . I ; Jasim, B.M. and Jarjees, M. T.. Seroprevalence of??? antibodies to Toxoplasmaosis , Brucellosis and Chamydiosis? In???? abortive? sheep in Nineveh? Iraq I .J. Vet .Sci.; (2014),? 28(1):21-25
  3. ALghamdi, J. ; Elamin , M.H. and Alhabib, S., Prevalence? and genotype of? Toxoplasma gondii among Saudi?? Pregnant women? in Saudi? Arabia .Saudi Pharm. J.: http://dx . doi.org110-1016/ j .JSPS.: 2015. 05. 001
  4. AL-Jebouri, M.; AL-Janabi , M. and? Ismail , H? . The? Prevalence? of toxoplasmosis? among? female? patients?? in?? AL-Hawija? and AL-Baiji Districts? in Iraq. Open J. Epidem. (2013)., 3:85-88
  5. AL-Hussien, E.F.A. ; Nassir , N.F. ; Kadhim , A.. Study of Prevalence and some immunological characteristics of Toxoplasma gondii infections in pregnant women . J. Babylon .Uni , (2016) 2: 24-26.
  6. Hassan , J.S. ; Ghazi , H .F. and Ahmed , A. A . . Rapid? evaluation of chromatographic? immuno? assay? with? Latex? , Agglutination? test? and? ELISA for diagnosis? of? human? toxoplasmosis .J. Fac. Med. Baghdad, (2010)? 52(4): 468-470.
  7. Nimir, A. ; Othman , A.; Ee , S.and Musa ,Z et al. Latent Toxoplasmosis? in patients? with? different? malignancy : Ahospital based? study .J. Clin. Med.? Res . (2015)., 2(3): 117? -120.
  8. Wang ,L.;He. ; Meng ,D.and Chen ,Z.et al. Seroprevalence and genetic characterization of Toxoplasma gondii in cancer patients in Anhui Proince ,Eastern China .J. Parasites & Vectors . .(2015),8:162.
  9. Mahmmad, M. ; Ahmed, S. and Hussain, A.,. Seroprevalence of Toxoplasma? gondii in couplas? in Remadi city using? enzyme linked? immunosorbent? assay (ELISA). Int.J.Med.Sci ., 2012, 4(3):? 55-59.
  10. Khudair, Mohammed Khalifa. Identifying toxoplasmosis in pregnant women in the province of Diyala. Diyala Journal of Pure Sciences, (2012), 8 (2): 1-8.
  11. Kalantari ,N. ; Ghaffari , S. ; Bayani , M. ; Elmi, M. ; Moslemi , D.; Nikbakhsh? ,N . and Ghavipanjeh , F. Preliminary study? on association??? between toxoplasmosis and? breast? cancer? in Iran. J. Asian Pac J .? ? Biomed . (2015), 5(1): 44-47.
  12. AL-Dujali, A .H. ; AL-Taei , W.F. ; Turky , K . M . and?? AI-Ubaidi ,? G. H.. Comparative study of? Ca19-9? levels? as? tumor? marker? in. sera? and? tissues? of?? patients?? with? stomach ?, colon? and? rectum??? cancer . J. Fac. Med . Baghdad (2009), 51(2): 223-226.
  13. Aabasian, L ; Shirbazou , S. ; Shamsi , M. ; Damghani , S. and Delpishen ,A.? . Hormonal changes in women with?? breast cancer??? infected with Toxoplasma gondii .J. Bas? . Res? .Med. Sci., (2016), 3(1):? 16-21.
  14. Ahmad Pour,? E , Daryani?? ,? A? ,? Sharifi? , , M . ; Sarui? , S. ; Aarabi ,? Mizan?? ; A ;? Rahimi,? T? .? and? shokri, A . (2015) . Toxoplasmosis? in? Immunocompromosed? pateints? in? Iran : a? systematic? reviews? and meta analysis. J .I.Develop.Count,8(12):1503-150.
  15. Ahmed, N. and Qayyum, M., Seroprevalence and risk factors for toxoplasmosis in large ruminants? in northern Punjab, Pakistan.J.?? Infect .Dev. Ctries. (2014), 8(8): 1022-1028.
  16. Deivendran, S. ;Marzook,K.H. and Radha Krishna , P.M.. The role of inflammation in cervical cancer. Adv.Exp.Med . (2014), 816: 377-399.
  17. Cong ,W.; Liu ,G.H. ; Meng ,Q.E. et al . Toxoplasma gondii? in cancer patients : prevalence , risk factors , Cancer letter .(2015),359(2):307-313.
  18. Morjaria, S. ; Epstein, D.J. and Romero, F.A. et al. Toxoplasma incephalitis in A typical hosts at an Academic Cancer Center . Open Forum Infect . Dis .(2016); 3(2): 070.
  19. Mclorman ,D.P. ; List, A. and Mufti, G.j. . Applying synthetic Lethality for the selective targeting? of cancer. N. Engl. J. Med . (2014), 37(18): 1725-1735.

[Daniah M. Hamid. (2017); PREVALENCE OF TOXOPLASMOSIS AMONG CANCER PATIENTS. Int. J. of Adv. Res. 5 (Jul). 1362-1366] (ISSN 2320-5407). www.journalijar.com


Daniah Muneam hamid


DOI:


Article DOI: 10.21474/IJAR01/4846      
DOI URL: http://dx.doi.org/10.21474/IJAR01/4846